[Seasonal allergic conjunctivitis]

Area of Science:

• Ophthalmology
• Allergology
• Immunology

Background:

• Seasonal allergic conjunctivitis (SAC) is a frequent ocular condition, often co-occurring with allergic rhinitis, forming allergic rhinoconjunctivitis.
• Unlike other chronic forms, SAC does not pose a threat to vision.
• Pathogenesis involves an immunoglobulin E (IgE)-mediated, Th2-driven type 1 hypersensitivity reaction.

Purpose of the Study:

• To outline the clinical presentation and management strategies for Seasonal Allergic Conjunctivitis (SAC).
• To discuss therapeutic goals including symptom relief, inflammation control, and prevention.
• To highlight the benefits of dual-action local therapeutics and specific immunotherapy.

Main Methods:

• Review of the pathophysiology of SAC, focusing on IgE-mediated hypersensitivity.
• Clinical description of SAC symptoms, including itching, conjunctival injection, and chemosis.
• Evaluation of treatment modalities, encompassing local therapeutics and immunotherapy.

Main Results:

• SAC presents clinically with itching, conjunctival injection, and chemosis.
• Dual-action local therapeutics provide rapid onset and sustained relief.
• Specific immunotherapy is a viable option for select patients.

Conclusions:

• Effective management of SAC involves symptom control, inflammation reduction, and preventive measures.
• Dual-action local treatments offer a balanced approach to symptom management.
• Individualized treatment plans, potentially including immunotherapy, are key for managing SAC.